Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guo-Ming Shi

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
The Oncologist|November 11, 2008
Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resectionGuo-Huan Yang, Jia Fan, Yang Xu, et al.
Annals of Surgical Oncology|March 14, 2012
Intratumoral IL-17⁺ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinomaFang-Ming Gu, Qiang Gao, Guo-Ming Shi, et al.
Cancer Letters|October 25, 2017
MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinomaXiu-Tao Fu, Ying-Hong Shi, Jian Zhou, et al.
Infectious Agents and Cancer|June 1, 2017
Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinomaXiu-Tao Fu, Ying-Hong Shi, Jian Zhou, et al.
American Journal of Cancer Research|January 29, 2015
Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysisZhao-Ru Dong, Peng-Fei Zhang, Cheng-Hao Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 7, 2014
Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinomaZhao-Ru Dong, Chi Zhang, Jia-Bin Cai, et al.
Annals of Translational Medicine|July 16, 2021
Simulation of portal/hepatic vein associated remnant liver ischemia/congestion by three-dimensional visualization technology based on preoperative CT scanXiao-Long Li, Bin Xu, Xiao-Dong Zhu, et al.
Cancer Letters|April 27, 2023
Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapyZhao-Ru Dong, Jia-Bin Cai, Guo-Ming Shi, et al.
Molecular Cancer|May 21, 2020
Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axisXiao-Yong Huang, Peng-Fei Zhang, Chuan-Yuan Wei, et al.
Journal of Cancer|November 21, 2017
Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A CirrhosisZhao-Ru Dong, Jie Zou, Dong Sun, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
The Oncologist|November 11, 2008
Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resectionGuo-Huan Yang, Jia Fan, Yang Xu, et al.
Annals of Surgical Oncology|March 14, 2012
Intratumoral IL-17⁺ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinomaFang-Ming Gu, Qiang Gao, Guo-Ming Shi, et al.
Cancer Letters|October 25, 2017
MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinomaXiu-Tao Fu, Ying-Hong Shi, Jian Zhou, et al.
Infectious Agents and Cancer|June 1, 2017
Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinomaXiu-Tao Fu, Ying-Hong Shi, Jian Zhou, et al.
American Journal of Cancer Research|January 29, 2015
Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysisZhao-Ru Dong, Peng-Fei Zhang, Cheng-Hao Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 7, 2014
Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinomaZhao-Ru Dong, Chi Zhang, Jia-Bin Cai, et al.
Annals of Translational Medicine|July 16, 2021
Simulation of portal/hepatic vein associated remnant liver ischemia/congestion by three-dimensional visualization technology based on preoperative CT scanXiao-Long Li, Bin Xu, Xiao-Dong Zhu, et al.
Cancer Letters|April 27, 2023
Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapyZhao-Ru Dong, Jia-Bin Cai, Guo-Ming Shi, et al.
Molecular Cancer|May 21, 2020
Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axisXiao-Yong Huang, Peng-Fei Zhang, Chuan-Yuan Wei, et al.
Journal of Cancer|November 21, 2017
Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A CirrhosisZhao-Ru Dong, Jie Zou, Dong Sun, et al.
Pageof 10